Tags

Type your tag names separated by a space and hit enter

Olfactory Dysfunction in COVID-19: Diagnosis and Management.
JAMA. 2020 Jun 23; 323(24):2512-2514.JAMA

Links

Publisher Full Text (DOI)

Authors+Show Affiliations

Whitcroft KL
Smell and Taste Clinic, Department of Otorhinolaryngology, TU Dresden, Dresden, Germany. UCL Ear Institute, University College London, London, United Kingdom.
Hummel T
Smell and Taste Clinic, Department of Otorhinolaryngology, TU Dresden, Dresden, Germany.

MeSH

BetacoronavirusCOVID-19COVID-19 TestingClinical Laboratory TechniquesCoronavirus InfectionsHumansOlfaction DisordersPandemicsPneumonia, ViralSARS-CoV-2

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

32432682

Clinical Trial Links

Fluvoxamine to Augment Olfactory Recovery For Long COVID-19 Parosmia

Citation

Whitcroft, Katherine Lisa, and Thomas Hummel. "Olfactory Dysfunction in COVID-19: Diagnosis and Management." JAMA, vol. 323, no. 24, 2020, pp. 2512-2514.
Whitcroft KL, Hummel T. Olfactory Dysfunction in COVID-19: Diagnosis and Management. JAMA. 2020;323(24):2512-2514.
Whitcroft, K. L., & Hummel, T. (2020). Olfactory Dysfunction in COVID-19: Diagnosis and Management. JAMA, 323(24), 2512-2514. https://doi.org/10.1001/jama.2020.8391
Whitcroft KL, Hummel T. Olfactory Dysfunction in COVID-19: Diagnosis and Management. JAMA. 2020 Jun 23;323(24):2512-2514. PubMed PMID: 32432682.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Olfactory Dysfunction in COVID-19: Diagnosis and Management. AU - Whitcroft,Katherine Lisa, AU - Hummel,Thomas, PY - 2020/5/21/pubmed PY - 2020/10/2/medline PY - 2020/5/21/entrez SP - 2512 EP - 2514 JF - JAMA JO - JAMA VL - 323 IS - 24 SN - 1538-3598 UR - https://www.unboundmedicine.com/medline/citation/32432682/Olfactory_Dysfunction_in_COVID_19:_Diagnosis_and_Management_ DB - PRIME DP - Unbound Medicine ER -